RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
9.11
-0.13 (-1.35%)
Sep 16, 2025, 4:00 PM EDT - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $372.54 million as of September 16, 2025. Its market cap has decreased by -82.76% in one year.
Market Cap
372.54M
Enterprise Value
168.02M
1-Year Change
-82.76%
Ranking
Category
Stock Price
$9.11
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $372.54M, a decrease of -12.21%. That is a compound annual growth rate of -3.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 377.65M | -72.75% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |